Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost side effects of oral semaglutide are gastrointestinal — nausea, loose stools, indigestion — and tend to be at their most noticeable in the first few weeks at a new dose, settling as your body adjusts. The MHRA approved Wegovy tablets for weight management in June 2026, and the clinical trial data show a clear side-effect profile that is manageable for most people but worth understanding before you start. Like all prescription-only weight-loss medicines, Wegovy tablets are only available following a prescriber's clinical assessment, which is where side effects and your individual health history are discussed properly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scene: it is 7am, you have taken your Wegovy tablet with a sip of water on a completely empty stomach, and an hour later you feel mildly queasy. That is the most typical experience people describe at the start of treatment, and it has a straightforward explanation. Oral semaglutide slows gastric emptying (food and stomach acid move through the gut more slowly than usual) and the body's initial response to this can be nausea, belching or a general sense that your stomach is unhappy with you.
In the OASIS 4 phase-3 trial (307 adults, 64 weeks), gastrointestinal side effects were reported by around 74% of participants taking oral semaglutide, compared with 42% on placebo. The majority were mild to moderate in intensity and transient. Nausea was the single most common complaint, followed by diarrhoea and constipation, sometimes alternating. Vomiting occurred less frequently but was more likely at the point of each dose increase. The NHS semaglutide medicines page notes that these effects are well characterised and do not, for most people, require stopping treatment.
A question our prescribers hear most weeks is whether the nausea means something has gone wrong. It usually does not. It tends to be strongest in the first one to two weeks at each dose level and then fades. Eating small, low-fat meals, keeping hydrated, and avoiding triggering foods like very greasy or spicy dishes can all help. For a fuller picture of how these effects compare across dose steps, the semaglutide tablet side effects by dose page goes into more detail.
Most side effects are an inconvenience rather than a danger. A small number of symptoms need prompt medical attention, and it is worth knowing them before you start rather than trying to look them up when you feel unwell.
Severe or persistent stomach pain that radiates to the back, particularly if accompanied by vomiting, should be treated as urgent. This combination can indicate acute pancreatitis. In January 2026 the MHRA published a Drug Safety Update confirming that pancreatitis is a known, if infrequent, risk with GLP-1 receptor agonist medicines; the update advises healthcare professionals and patients to be alert to this presentation. If you experience it, stop taking the medicine and seek emergency care. The MHRA's Yellow Card scheme exists precisely so that reports like this feed back into ongoing safety monitoring, anyone, patient or carer, can file a report online.
Other symptoms that warrant contacting a doctor or pharmacist promptly include signs of a severe allergic reaction (throat swelling, difficulty breathing, widespread rash), gallbladder pain (sharp pain in the upper right abdomen, especially after eating), and signs of dehydration from prolonged vomiting or diarrhoea (dizziness, dark urine, rapid heartbeat). If you are unsure whether a symptom is serious, contacting your prescriber is always the right call. At nume, aftercare support is available seven days a week precisely for moments like this; you can reach the team via the contact page.
Beyond the gut, some people notice fatigue or mild headaches, particularly in the first week at a new dose. These generally resolve without intervention. Injection-site reactions are not relevant here (oral semaglutide has no injection) but the tablet's absorption is uniquely sensitive to how it is taken, and getting this wrong can mimic or worsen side effects.
The tablet must be swallowed whole, first thing in the morning, with no more than about 120ml of plain water. Nothing else (no coffee, no breakfast, no other tablets or capsules) should follow for at least 30 minutes. This is not a guideline that has much flexibility: the absorption enhancer (SNAC) that makes oral semaglutide possible only works reliably in a fasted, low-acid stomach environment. Taking the tablet after even a small amount of food can reduce absorption significantly, and erratic absorption can itself produce a more turbulent side-effect pattern. The Wegovy tablet SmPC on the eMC sets this out in full and is worth reading alongside the patient information leaflet supplied with your medicine.
People who are pregnant, breastfeeding, or planning to conceive should not use oral semaglutide; it is not licensed for those under 18. If any of those circumstances apply to you, your prescriber will discuss the situation clearly. For those considering the tablet alongside existing medication or conditions, the safety overview for semaglutide tablets covers interactions and contraindications in more depth.
Side effects do not arrive as a surprise in a well-run clinical process. At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber, a real clinician reading your answers, not a system auto-approving them. They look at your medical history, current medicines, and any relevant conditions before deciding whether oral semaglutide is appropriate for you and at what starting dose.
The dose schedule exists in part precisely to manage side effects: starting at 1.5mg and moving through 4mg, then the 9mg step where some people notice a fresh wave of semaglutide 7mg tablet side effects worth understanding in advance, and then the 25mg maintenance dose over several months gives your body time to adapt at each step. Rushing that process, or starting at a dose above what is clinically appropriate, is one of the most common reasons side effects become hard to tolerate. If you want a broader view of what to expect from the tablet form of the medicine, our guide to semaglutide tablets side effects walks through the full picture. Similarly, if you have been reading about the pill formulation and wondering how it compares, the overview of semaglutide pills side effects explains where the two overlap and where they differ. To discuss your specific situation and whether oral semaglutide suits you, our prescribers are available through a free consultation, with no obligation to proceed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.